ThursdayAug 29, 2019 9:40 am

QualityStocksNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Releases Q1 Financial Results, Provides Solace Acquisition Update

Geyser Brands (TSX.V: GYSR) this morning released its first quarter financial statements for the three months ended June 30, 2019. According to the update, the company generated its first revenues of $79,434 during the quarter and reported $64,690 in gross profit, representing an 81 percent gross profit margin. In addition, Geyser Brands announced that, in connection with its conditional approval of the Solace Management Group Inc. acquisition, it is submitting all information to the TSX Venture Exchange for review. “We have begun to operationalize our manufacturing and processing capabilities, generating our first revenues during Q1,” GYSR CEO Andreas Thatcher said…

Continue Reading

FridayAug 23, 2019 1:04 pm

QualityStocksNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Subsidiary Attains License, Enables Health Care Brands to Add CBD

Global science-led consumer health-care company Geyser Brands’ (TSX.V: GYSR) wholly owned subsidiary, Apothecary Botanicals, has received a standard processing license from Health Canada. A recent article discussing the company reads, “‘The license allows us to add value to existing consumer health care brands by providing them the platform to add CBD,’ Geyser CEO Andreas Thatcher stated in a news release (http://ibn.fm/eKxTj). ‘It also reflects our business model to focus our licensed producer on delivering scale through manufacturing and distribution for brand companies.’ . . . The new license allows Geyser to begin work to extend its cannabidiol products to the…

Continue Reading

FridayAug 23, 2019 11:52 am

The Future of Cannabis Edibles is Nanoemulsions, Geyser Brands Inc. (TSX.V: GYSR) Offering Advanced Delivery System

Nanoemulsions play an important role in the cannabis formulation market, because they provide a reliable solution to bioavailability and insolubility problems The nanoemulsion market is expected to grow steadily and reach a value of $14.91 billion by 2025 Geyser Brands has already established itself as a nanoemulsion pioneer through the development of its proprietary and highly effective NanoFusion technology As cannabis edibles and beverages are becoming more popular, the nanoemulsions market is experiencing rapid growth. Nanoemulsion-infused cannabis beverages offer a solution to some of the most common problems that the sector is facing, including the limited efficacy of hemp-derived products…

Continue Reading

WednesdayAug 21, 2019 1:00 pm

Geyser Brands Inc. (TSX.V: GYSR) Sees Global Opportunities in Growing Portfolio of Health-Focused CBD, Hemp Product Lines

Geyser Brands continues to strengthen its leadership team with industry leaders The company’s proprietary nanotechnology formulations transport therapeutic agents with superior bioavailability and efficacy Geyser Brands is pursuing the acquisition of Solace Management Group, solidifying its place as a leading provider of health-focused CBD and hemp products Geyser Brands Inc. (TSX.V: GYSR), a global science-led consumer health care company, builds and markets some of the world’s leading cannabis products and brands. As a licensed producer in Canada under the Cannabis Act, Geyser operates a production and processing facility in Port Coquitlam, British Columbia, developing unique products for healthy lifestyle brands (http://ibn.fm/SFy2J).…

Continue Reading

MondayJul 29, 2019 9:59 am

QualityStocksNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Releases Post-RTO Financial Results for the 8-months ended March 31, 2019

Geyser Brands (TSX.V: GYSR) this morning announced its post-RTO audited financial statements ("Annual Financial Statement") for the 8-months ended March 31, 2019, as well as accompanying management discussion and analysis. According to the update, the Annual Financial Statement represents Geyser’s transitional fiscal year following its RTO and change in the fiscal year end, which is further described in the Notice of Change in Corporate Structure filed on the company's SEDAR profile. “We are pleased with our progress in the first 8 months since completing the RTO.  Our subsidiary, 0957203 B.C. Ltd. dba Apothecary Botanicals, through its strong management, has been…

Continue Reading

FridayJul 19, 2019 1:03 pm

QualityStocksNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Appoints Seasoned Life Sciences Executive to Board of Directors

Geyser Brands (TSX.V: GYSR) announced key appointments to its leadership team recently, including the addition of Dr. Bin Huang to the company’s board of directors (http://ibn.fm/ElFjT). An article discussing the company reads, “Joining the board of directors is Dr. Bin Huang, a seasoned, life-sciences executive with experience in strategy and new business development, financing and public markets, corporate governance and operations management in North America and Asia. She most recently served as CEO of Emerald Health Therapeutics Inc. and has held senior-management roles in both startups and Fortune 500 corporations. Huang holds a PhD in plant cell biology from the…

Continue Reading

ThursdayJul 11, 2019 3:25 pm

QualityStocksNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Subsidiary Secures Coveted Standard Processing License

Geyser Brands’ (TSX.V: GYSR) wholly owned subsidiary, Apothecary Botanicals, recently achieved a major milestone when it received its standard processing license, enabling Geyser to advance its brands (http://ibn.fm/97gi1). An article discussing the company reads, “The new license allows Geyser to begin work to extend its cannabidiol products to the regulated Canadian consumer medical market as the company awaits its sales license. The company’s nano-emulsion technology carries oil and hemp terpene-infused benefits quickly and efficiently into the bloodstream for rapid relief of pain while boosting the body’s general abilities with all-natural ingredients. . . . In keeping with its mission to…

Continue Reading

ThursdayJul 11, 2019 12:09 pm

Geyser Brands Inc. (TSX.V: GYSR) Strengthens Leadership with Key Appointments

Seasoned life sciences executive Dr. Bin Huang has been appointed to the Geyser board of directors Chartered Professional Account Gordon Clissold has been named chief executive officer Geyser Brands is entering into a definitive agreement for the acquisition of Solace Management Group, which will broaden the company’s range of CBD- and hemp-based products Geyser Brands Inc. (TSX.V: GYSR), a leading consumer health care company based in Vancouver, British Columbia, builds health-based hemp CBD consumer products in the worldwide nutraceutical, cosmetics, food & beverage and pet sectors. Recent pivotal appointments to Geyser Brand’s leadership team are expected to strengthen the company’s…

Continue Reading

TuesdayJul 09, 2019 11:00 am

Geyser Brands Inc. (TSX.V: GYSR) Reaches Milestone in CBD Wellness Market with Reception of Processing License

Geyser Brands is a cannabis consumer wellness company dedicated to helping people look, feel and do their best The company announced June 18 that wholly owned subsidiary Apothecary Botanicals has been awarded a processing license, allowing GYSR to advance its brands Geyser’s LOI to acquire Solace Management Group is expected to give the company additional wellness brands for humans and their pets, once due diligence is completed Consumer wellness brand cultivator Geyser Brands Inc. (TSX.V: GYSR) is moving forward with its vision of developing premier cannabis-enhanced products following Health Canada’s announcement that the company’s wholly owned subsidiary, Apothecary Botanicals (0957102…

Continue Reading

FridayJul 05, 2019 1:45 pm

QualityStocksNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Leverages Proprietary NanoFusion Delivery System throughout Cannabis Industry

Vancouver, British Columbia-based consumer health care company Geyser Brands (TSX.V: GYSR) is engaged in creating first-class, cannabis-focused health care products and brands. A recent article discussing the company reads, “Geyser’s NanoFusion advanced delivery system rapidly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency. NanoFusion provides premier bioavailability and solves problems with insolubility. It also provides a longer shelf life, stability of molecules and enhanced permeation that allows for deeper skin penetration. Moreover, NanoFusion​ improves the transport of active ingredients for site-specific targeting and delivers active ingredients across cell membranes for release within the cell. Its proprietary…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered